High Yield Production of Influenza Virus in Madin Darby Canine Kidney (MDCK) Cells with Stable Knockdown of IRF7

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Hamamoto, Itsuki ^a   Takaku, Hiroshi ^b   Tashiro, Masato ^a   Yamamoto, Norio ^a,c  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b CHIBA INSTITUTE OF TECHNOLOGY   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; INFLUENZA VACCINE; INTERFERON REGULATORY FACTOR 7; LENTIVIRUS VECTOR; MYELOID DIFFERENTIATION FACTOR 88; RETINOIC ACID INDUCIBLE PROTEIN I; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE IDENTIFICATION; GENE SILENCING; GENE TARGETING; INFLUENZA VIRUS; INTERFERON REGULATORY FACTOR 7 GENE; INTRACELLULAR SIGNALING; MDCK CELL; NONHUMAN; PROTEIN INDUCTION; SEQUENCE ANALYSIS; VACCINE PRODUCTION; VIROGENESIS; VIRUS ISOLATION; VIRUS LOAD;

ANIMALS; CELL LINE, TUMOR; DOGS; GENE LIBRARY; HUMANS; INFLUENZA VACCINES; INTERFERON REGULATORY FACTOR-7; INTERFERON TYPE I; MADIN DARBY CANINE KIDNEY CELLS; ORTHOMYXOVIRIDAE; PLASMIDS; RNA, SMALL INTERFERING; VIRUS CULTIVATION; VIRUS REPLICATION;

ORTHOMYXOVIRIDAE;

EID: 84875475566     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059892     Document Type: Article

References (32)

1. Kistner O, Barrett PN, Mundt W, Reiter M, Schober-Bendixen S, et al. (1998) Development of a mammalian cell (Vero) derived candidate influenza virus vaccine. Vaccine 16: 960-968.
2. Kistner O, Barrett PN, Mundt W, Reiter M, Schober-Bendixen S, et al. (1999) A novel mammalian cell (Vero) derived influenza virus vaccine: development, characterization and industrial scale production. Wiener klinische Wochenschrift 111: 207-214.
3. Halperin SA, Smith B, Mabrouk T, Germain M, Trepanier P, et al. (2002) Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children. Vaccine 20: 1240-1247.
4. Doroshenko A, Halperin SA, (2009) Trivalent MDCK cell culture-derived influenza vaccine Optaflu (Novartis Vaccines). Expert review of vaccines 8: 679-688.
5. Chu C, Lugovtsev V, Golding H, Betenbaugh M, Shiloach J, (2009) Conversion of MDCK cell line to suspension culture by transfecting with human siat7e gene and its application for influenza virus production. Proceedings of the National Academy of Sciences of the United States of America 106: 14802-14807.
6. Pau MG, Ophorst C, Koldijk MH, Schouten G, Mehtali M, et al. (2001) The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines. Vaccine 19: 2716-2721.
7. Le Goffic R, Pothlichet J, Vitour D, Fujita T, Meurs E, et al. (2007) Cutting Edge: Influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. Journal of immunology 178: 3368-3372.
8. Wang JP, Bowen GN, Padden C, Cerny A, Finberg RW, et al. (2008) Toll-like receptor-mediated activation of neutrophils by influenza A virus. Blood 112: 2028-2034.
9. Opitz B, Rejaibi A, Dauber B, Eckhard J, Vinzing M, et al. (2007) IFNbeta induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein. Cellular microbiology 9: 930-938.
10. Bonjardim CA, Ferreira PC, Kroon EG, (2009) Interferons: signaling, antiviral and viral evasion. Immunology letters 122: 1-11.
11. Garcia-Sastre A, Egorov A, Matassov D, Brandt S, Levy DE, et al. (1998) Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252: 324-330.
12. Takeuchi O, Akira S, (2010) Pattern recognition receptors and inflammation. Cell 140: 805-820.
13. Stetson DB, Medzhitov R, (2006) Type I interferons in host defense. Immunity 25: 373-381.
14. Theofilopoulos AN, Baccala R, Beutler B, Kono DH, (2005) Type I interferons (alpha/beta) in immunity and autoimmunity. Annual review of immunology 23: 307-336.
15. Wood JS, Robertson JS, (2007) Reference viruses for seasonal and pandemic influenza vaccine preparation. Influenza and other respiratory viruses 1: 5-9.
16. de Vries W, Haasnoot J, van der Velden J, van Montfort T, Zorgdrager F, et al. (2008) Increased virus replication in mammalian cells by blocking intracellular innate defense responses. Gene therapy 15: 545-552.
17. Sherwood V, Burgert HG, Chen YH, Sanghera S, Katafigiotis S, et al. (2007) Improved growth of enteric adenovirus type 40 in a modified cell line that can no longer respond to interferon stimulation. The Journal of general virology 88: 71-76.
18. Young DF, Andrejeva L, Livingstone A, Goodbourn S, Lamb RA, et al. (2003) Virus replication in engineered human cells that do not respond to interferons. Journal of virology 77: 2174-2181.
19. Sabbah A, Chang TH, Harnack R, Frohlich V, Tominaga K, et al. (2009) Activation of innate immune antiviral responses by Nod2. Nature immunology 10: 1073-1080.
20. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, et al. (2005) IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434: 772-777.
21. Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, et al. (2000) Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13: 539-548.
22. Honda K, Taniguchi T, (2006) IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nature reviews Immunology 6: 644-658.
23. Garcia-Sastre A, Biron CA, (2006) Type 1 interferons and the virus-host relationship: a lesson in detente. Science 312: 879-882.
24. Haller O, Kochs G, Weber F, (2006) The interferon response circuit: induction and suppression by pathogenic viruses. Virology 344: 119-130.
25. Das K, Ma LC, Xiao R, Radvansky B, Aramini J, et al. (2008) Structural basis for suppression of a host antiviral response by influenza A virus. Proceedings of the National Academy of Sciences of the United States of America 105: 13093-13098.
26. Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, et al. (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science 314: 997-1001.
27. Mibayashi M, Martinez-Sobrido L, Loo YM, Cardenas WB, Gale M Jr, et al. (2007) Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. Journal of virology 81: 514-524.
28. Gack MU, Albrecht RA, Urano T, Inn KS, Huang IC, et al. (2009) Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell host & microbe 5: 439-449.
29. Wang X, Li M, Zheng H, Muster T, Palese P, et al. (2000) Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. Journal of virology 74: 11566-11573.
30. Donelan NR, Dauber B, Wang X, Basler CF, Wolff T, et al. (2004) The N- and C-terminal domains of the NS1 protein of influenza B virus can independently inhibit IRF-3 and beta interferon promoter activation. Journal of virology 78: 11574-11582.
31. Graef KM, Vreede FT, Lau YF, McCall AW, Carr SM, et al. (2010) The PB2 subunit of the influenza virus RNA polymerase affects virulence by interacting with the mitochondrial antiviral signaling protein and inhibiting expression of beta interferon. Journal of virology 84: 8433-8445.
32. Varga ZT, Ramos I, Hai R, Schmolke M, Garcia-Sastre A, et al. (2011) The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein. PLoS pathogens 7: e1002067.